Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: In vitro and in vivo studies

Drug Development and Industrial Pharmacy

Volumn 29, Issue 2, 2003, Pages 215-221

  Charoo, Naseem A ^a   Kohli, Kanchan ^a   Ali, Asgar ^a   Anwer, Areeg ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Bacterial conjunctivitis; Ciprofloxacin hydrochloride; Ocular inserts

Indexed keywords

CIPROFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; AQUEOUS HUMOR; ARTICLE; CONJUNCTIVITIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; GAMMA RADIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATIENT COMPLIANCE; PLASMA HALF LIFE; POLYMERIZATION; RABBIT; SHELF LIFE;

EID: 0037219622     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120016729     Document Type: Article

References (11)

1. Shell, J.W. Therapeutic reviews of ophthalmic drug delivery systems. Survey of Ophthalmology 1984, 29 (2), 117-128.
2. Chien, Y.W. Controlled and modulated release drug delivery systems. In Encyclopedia of Pharmaceutical Technology; Marcel Dekker Inc.: New York, 1995; Vol. 3.
3. Kamath, R.; Singh, U.V.; Udapa, N. Evaluation of ciprofloxacin hydrochloride ocular preparations. Ind. J. Pharm. Sci. 1993, 55, 148-150.
4. Tsai, A.C.; Chang, S.W.; Tseng, M.C. Clinical evaluation of ciprofloxacin ophthalmic solution in the treatment of refractory bacterial keratitis. J. Formos. Med. Assoc. 1995, 94 (12), 760.
5. Ciprofloxacin hydrochloride, analytical report. Control no. 197210, W.H.O. Guidelines. W.H.O./Pharm./97, 595, 57-65.
6. Ali, A.; Sharma, S.N. Fabrication of a through flow apparatus for in-vitro determination of drugs from ophthalmic preparations. Ind. Drugs 1992, 29 (4), 157-160.
7. Chi Lee, Y.; Jeffrey, W.; Gerald, J. Formulation and in-vitro evaluation of ocular insert containing phenylephrine and tropicamide. Int. J. Pharm. 1999, 182, 121-126.
8. Osman, C.; Cosar, B.; Yasar, U.; Atilla, F. Comparison of aqueous humour and vitreous humour levels of two 0.3% ciprofloxacin eye drops. Can. J. Ophthalmol. 1998, 33, 373-376.
9. Keyserlingk, I.; Beck, R.; Fisclier, U.; Drewelow, B. Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humour of patients by different topical application modes. Int. J. Clin. Pharmacol. 1997, 534, 251-255.
10. Pauline, M.; Norman, M.; Rogger, W. High pressure liquid chromatographic methods for ciprofloxacin hydrochloride and related compounds in raw materials, J. Pharm. and Biomed. Analysis 1996, 14, 641-654,
11. Hu, F.R.; Luh, K.T. Topical ciprofloxacin for treating mycobacterial keratitis. Ophthalmology 1998, 105 (2), 269.